CUSIP 64136E102COMNEUPQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
21 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 875.2K | $3.40M | +875.2K | New |
| 2 | Shay Capital LLC | 169.1K | $655.9K | +169.1K | New |
| 3 | Advisorshares Investments LLC | 134.2K | $520.7K | +75.6K | Added |
| 4 | Diadema Partners LP | 50.0K | $194.0K |
| +28.5K |
| Added |
| 5 | Ikarian Capital, LLC | 47.4K | $184.1K | +47.4K | New |
| 6 | Adar1 Capital Management, LLC | 30.0K | $116.4K | +30.0K | New |
| 7 | Vanguard Group Inc | 20.9K | $81.3K | 0 | Held |
| 8 | Geode Capital Management, LLC | 17.3K | $67.1K | +4.3K | Added |
| 9 | Jane Street Group, LLC | 16.6K | $64.4K | +928 | Added |
| 10 | Bridgeway Capital Management, LLC | 14.8K | $57.2K | +14.8K | New |
See every fund holding Neuphoria Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders